An internal complaint (b)(4) was received indicating that the plunger of a syringe (part number (b)(4), lot iaf661510) became crooked, allowing for contrast fluid to leak.A sample was received for evaluation.The sample and a supplier corrective action request (scar) were forwarded to coeur, inc., who supplies the syringe to deroyal.A reply is due back (b)(6), 2016.The investigation is ongoing at this time.This report will be updated when new and critical information is received.
|
Root cause: the syringe is supplied to deroyal by (b)(4).Therefore, a supplier corrective action response (scar) was issued to coeur.In its response, (b)(4) stated it was unable to determine a true root cause.In reviewing the returned and retained samples, the device history record, and the fixtures used during assembly, (b)(4) confirmed the device was assembled correctly.A possible root cause is misalignment by the end user.Corrective action: in its scar response, (b)(4) stated it has issued a quality alert to raise awareness among its operators, assemblers, and inspection personnel of the need for proper plunger alignment.Investigation summary: an internal complaint (call (b)(4)) was received indicating that the plunger of a syringe (part number 77-400277, lot iaf661510) became crooked, allowing for contrast fluid to leak.A sample was received for evaluation.The sample and a supplier corrective action request (scar) were forwarded to (b)(4), who supplies the syringe to deroyal.A reply was due november 22, 2016, and received december 15, 2016.Deroyal quality personnel has reviewed and accepted the response.In its response, (b)(4) stated it reviewed the returned samples as well as retained samples and found them to be assembled correctly and functioning properly.It also reviewed the fixtures and confirmed they are building product correctly.Deroyal personnel reviewed the reported lot number for discrepancies that may have contributed to the reported event.No discrepancies were identified.Preventive action: a preventive action has not been taken.The investigation is complete at this time.If new and critical information is received, this report will be updated.
|